CAIAFFA, MARIA FILOMENA
 Distribuzione geografica
Continente #
EU - Europa 4.046
NA - Nord America 3.915
AS - Asia 2.040
SA - Sud America 221
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 2
Totale 10.250
Nazione #
US - Stati Uniti d'America 3.893
IE - Irlanda 1.090
CN - Cina 1.080
UA - Ucraina 770
SE - Svezia 557
IT - Italia 495
SG - Singapore 327
RU - Federazione Russa 326
HK - Hong Kong 275
BR - Brasile 201
FR - Francia 190
DE - Germania 183
FI - Finlandia 177
TR - Turchia 162
GB - Regno Unito 107
IN - India 103
BE - Belgio 52
VN - Vietnam 41
CZ - Repubblica Ceca 28
CA - Canada 19
RO - Romania 13
IR - Iran 12
EU - Europa 10
NL - Olanda 9
RS - Serbia 8
ES - Italia 7
GR - Grecia 7
AT - Austria 6
IQ - Iraq 5
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
UZ - Uzbekistan 5
CL - Cile 4
EC - Ecuador 4
ID - Indonesia 4
TH - Thailandia 4
TN - Tunisia 4
ZA - Sudafrica 4
CI - Costa d'Avorio 3
CO - Colombia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AR - Argentina 2
AU - Australia 2
BD - Bangladesh 2
CH - Svizzera 2
IL - Israele 2
JP - Giappone 2
MT - Malta 2
MX - Messico 2
PE - Perù 2
PL - Polonia 2
PS - Palestinian Territory 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AZ - Azerbaigian 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
Totale 10.250
Città #
Dublin 1.090
Chandler 588
Jacksonville 539
Dearborn 455
Nyköping 331
Nanjing 278
Hong Kong 272
Ashburn 206
Wilmington 175
Beijing 144
Santa Clara 144
Princeton 122
Singapore 104
Munich 103
Nanchang 102
San Mateo 102
Ann Arbor 99
Helsinki 80
Woodbridge 72
Shenyang 70
Boardman 67
Des Moines 64
The Dalles 63
New York 57
Foggia 54
Moscow 53
Brussels 51
Jiaxing 46
Hebei 43
Tianjin 43
Kunming 41
Dong Ket 38
Bari 36
Guangzhou 29
Pune 29
Rome 28
Changsha 26
Jinan 25
Seattle 25
Los Angeles 21
Hangzhou 20
Brno 19
London 19
Milan 19
Auburn Hills 17
Shanghai 17
Ningbo 15
Changchun 14
Stevenage 13
Toronto 13
Zhengzhou 13
Augusta 12
Washington 12
Hilden 11
Taizhou 11
São Paulo 10
Bologna 9
Hefei 9
Lanzhou 9
Olomouc 9
Shenzhen 9
Orange 8
Philadelphia 8
West Jordan 8
Florence 7
Lucera 7
Redwood City 7
Timisoara 7
Falkenstein 6
Leawood 6
Ardabil 5
Chicago 5
Columbus 5
Nuremberg 5
Rio de Janeiro 5
Saint Petersburg 5
Yiwu 5
Bangkok 4
Belgrade 4
Capua 4
Catania 4
Cisternino 4
Frankfurt am Main 4
Guarulhos 4
Hanover 4
Houston 4
Istanbul 4
Jyväskylä 4
Manfredonia 4
Salvador 4
San Marzano Di San Giuseppe 4
Tashkent 4
Tunis 4
Turin 4
Walnut 4
Wuxi 4
Abidjan 3
Baghdad 3
Banská Bystrica 3
Bellante 3
Totale 6.382
Nome #
A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy 359
Il fenetil estere dell'acido caffeico è un potente inibitore della via metabolica 5-lipossigenasica/leucotrienica 202
Sviluppo ed applicazione di un protocollo di desensibilizzazione rapida per Rituximab 184
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia crociata a fico e gelsi 151
Multicenter double-blind comparative study of terfenadine and cetirizine in hay fever. 123
Terapia con Omalizumab nell'asma severo persistente: presentazione di un caso clinico 123
Allergy to artichoke: a case report. 120
Fusaproliferin production by Fusarium subglutinans and toxicity to Artemia salina, SF-9 insect cells and IARC/LCL 171 human B-lymphocytes. 119
"Metodo diagnostico in vitro per allergia respiratoria da polline di Cupressus arizonica". 116
5-lipoxygenase upregulation by dexamethasone in human mast cells. 116
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet 114
Caratterizzazione di nuovi allergeni alimentari della dieta mediterranea: allergia al carciofo 111
Terapia con Omalizumab: valutazione di efficacia e tollerabilità in una casistica di 21 soggetti con asma severo non controllato 111
Apoptosis induced by the Fusarium mycotoxin beauvericin in mammalian cells. 110
Allergia alimentare a Leguminose della dieta mediterranea: Phaseoulus vulgaris (fagiolo) e Pisum Sativum (pisello) 107
Novel inhibitory effect on 5-lipoxygenase activity by montelukast. Evedence for a noncopetitive mode of action 106
Allergia alimentare da finocchio (Phoeniculum Vulgare) ed altre Apiaceae 105
Sviluppo ed applicazione di una procedura di monitoring dell'asma persistente basato su registrazione di sintomi e PEF 104
Tako-tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 104
Olive pollen allergy in Bari, Italy. 103
Flaws and improvement in skin testing in Hymenoptera venom allergy. 103
General adverse reaction to aspirin administered by transdermal iontophoresis. 102
Expression of prostaglandin endoperoxide H synthase 1 and 2 in human placenta at term 102
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy. 102
Development and application of an improved sympton score and PEF card-based procedure in the management of persistent asthma 101
Grape anaphylaxis 99
EFFETTI DEL MONTELUKAST SULLA BIOSINTESI DEI LEUCOTRIENI E SULL'ATTIVITA' ENZIMATICA DELLA 5-LO 98
Allergeni alimentari emergenti della dieta mediterranea 98
Biosensori cellulari nella valutazione di nuovi detergenti ecosostenibili. 97
Cyclooxygenase-2 expression in oral squamous cell carcinoma 97
Allergy to pomegranate and artichoke, novel food allergens of the Mediterranean diet. 95
Five-lipoxygenase/leukotreiene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-infiammatory properties. 94
Changes in skin reactivity, specific IgE and IgG levels after 1 year of immunotherapy in olive pollinosis. 93
Allergens of Arizona cypress (Cupressus arizonica) pollen: characterization of the pollen extract and identification of the allergenic components. 93
Characteristics and treatment regimens across ERS SHARP severe asthma registries 93
Airborne Cupressaceae pollen in Southern Italy 92
Beauvericin cytotoxicity to the invertebrate cell line SF-9. 91
Nuove acquisizioni sul meccanismo di azione dei corticosteroidi. 91
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and cypress pollen 91
Wasp immunotherapy induces a long term and IgG4-independent protection. 91
Omalizumab in severe allergic asthma: efficacy assessment by comparison of pre- and post-therapy symptom score and peak espiratory flow (PEF) values. 90
Allergy to pomegranate and artichoke, novel food allergens of the mediterranean diet. 90
Significativo declino dei valori di IgE specifiche legate, evidenziato da skin prick tests quantitativi, in pazienti con asma severo trattati con omalizumab 90
Novel inibitory effect on 5-lipoxygenase by the anti-asthma drug montelukast 88
Flaws and improvements in skin testing in hymenoptera venom allergy 88
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: VALUTAZIONE DI EFFICACIA E TOLLERABILITA' IN UNA CASISTICA DI TRENTA PAZIENTI 88
A new subcutaneous protocol for persistent desensitisation to Rituximab. 88
Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug montelukast 87
Therapy with omalizumab: evaluation of effectiveness and safety in 27 patients with severe uncontrolled asthma. 87
Monitoring of atmospheric conditions and forecast of olive pollen season. 86
TERAPIA CON OMALIZUMAB NELL'ASMA SEVERO NON CONTROLLATO: PRESENTAZIONE DI UN CASO CLINICO 86
Five-lipoxygenase/leukotriene pathway inhibition by caffeic acid phenethyl ester, caffeic acid and chlorogenic acid, natural products with anti-oxidant and anti-inflammatory properties. 85
Fennel (Foeniculum vulgare); a major allergen of the Mediterranean diet 84
Italian real-life experience of omalizumab. 83
Cyclooxygenase-2 expression in oral squamous cell carcinoma. 82
Omalizumab e monitoraggio retrospettivo dei sintomi e del PEF nell'asma severo non controllato 82
Allergia alimentare da finocchio (Phoeniculum vulgare) ed altre Apiaceae 82
Retrospective monitoring in the management of persistent asthma 82
Fig and mulberry cross-allergy 81
Purification and fine characterization of the major allergen from Olea europaea pollen extract. 81
Management dell'anafilassi da alimenti 80
Skin testing technique and precision in stinging insect allergy 79
Food Allergy in Southern Italy. Allergy to cynara scolymus 78
Systemic adverse reaction to diclofenac administered by transdermal iontophoresis. 77
Efficacia e tollerabilità di Omalizumab (Xolair) dopo due anni di trattamento: studio in 17 soggetti con asma severo 77
Indirect food contact in severe fish allergy. 76
Impact of Omalizumab in 21 patients with severe asthma 76
Novel food allergens of the Mediterranean diet. 76
Punti di debolezza ed ottimizzazione dei tests cutanei nell'allergia a veleno di imenotteri 76
Tako-Tsubo cardiomyopathy following an allergic asthma attack after cephalosporin administration. 76
Dermanyssus gallinae in città: serve un approccio multiattoriale in cui il veterinario è decisivo 76
Leukotriene biosyntesis inhibition and direct 5-lipoxygenase non competitive inhibition by the Cys-LT1 receptor antagonists montelukast ans zafirlukast. 75
Skin testing technique and precision in stinging insect allergy 75
Cytotoxic effects of the mycotoxin beauvericin to human cell lines of myeloid origin. 74
Tests cutanei nel monitoraggio dell'immunoterapia a veleno di imenotteri 74
Leukotriene biosynthesis inhibition and direct 5-lipoxygenase (5-LO) noncompetitive inhibition by the cys-LT1 receptor antagonist montelukast. 73
Omalizumab and retrospective syntom score and PEF monitoring in severe asthma 72
L'orticaria (da un punto di vista allergologico) 72
Omalizumab in severe allergic asthma: efficacy assessment by comparison of symptom score and peak espiratory flow values before and after therapy. J Investig Allergol Clin Immunol; 72
Terapia dell'asma severo con anticorpo monoclonale anti-IgE. Significativo declino dei valori di IgE specifiche legate, evidenziato da Skin Prick Tests Quantitativi. 72
Fennel (Foeniculum vulgare) allergy. Nico A, Vacca M, Bellotti A, Di Giacomo M, Giliberti A, Lotti A, Caiaffa MF, Macchia L. 72
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 72
Desensitization in Iron Product Allergy 71
Immunological characterization of onion (Allium cepa) allergy 68
Maintenance-Phase Subcutaneous Immunotherapy with House Dust Mites Induces Cyclic Immunologic Effects 68
Studi "in vivo" sulla cross-reattività allergenica tra polline di Compositae anemofile e Compositae edibili 67
The lymphocyte proliferation test (LTP) in the diagnosis of critical cases of delayed drug allergy. 67
Italian real-life experience of omalizumab 66
Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis. A systematic review and meta-analysis. 66
Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study 66
Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study 66
Purification and fine characterization of the major allergen from Olea Europaea pollen extract. 65
Second generation antihistamines in the treatment of seasonal allergic rhinitis due to Parietaria and Cypress pollen 65
A desensitization protocol for delayed allergy to cytarabine: Analysis of two cases 65
Cost-effectiveness of grass pollen allergen immunotherapy in adults 65
Il ruolo organizzativo e pedagogico del Presidente di Corso di Laurea Magistrale in Medicina. 64
Desensitization for immediate hypersensitivity to oral dimethyl fumarate (Tecfidera) 64
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 64
Retrospective monitoring in the management of persistent asthma. 61
Fennel (Phoeniculum vulgare) allergy 60
Totale 9.149
Categoria #
all - tutte 52.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 0 0 0 0 0 0 0 143 35
2020/20211.087 141 13 123 6 122 66 149 71 172 162 12 50
2021/2022715 102 1 7 23 62 21 26 53 98 70 33 219
2022/20232.690 242 114 121 161 148 247 47 203 1.249 39 59 60
2023/2024620 78 19 28 17 58 227 16 68 1 15 12 81
2024/20251.882 108 15 124 74 75 307 240 183 565 174 17 0
Totale 10.499